Bowling Portfolio Management LLC Purchases 2,734 Shares of UnitedHealth Group Inc (NYSE:UNH)

Bowling Portfolio Management LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 61.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,172 shares of the healthcare conglomerate’s stock after acquiring an additional 2,734 shares during the period. Bowling Portfolio Management LLC’s holdings in UnitedHealth Group were worth $1,773,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc lifted its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after purchasing an additional 1,073,505 shares during the period. BKD Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 18.0% in the fourth quarter. BKD Wealth Advisors LLC now owns 6,064 shares of the healthcare conglomerate’s stock worth $1,511,000 after purchasing an additional 926 shares during the last quarter. Strategic Advisors LLC raised its stake in shares of UnitedHealth Group by 46.7% in the fourth quarter. Strategic Advisors LLC now owns 4,695 shares of the healthcare conglomerate’s stock worth $1,170,000 after purchasing an additional 1,495 shares during the last quarter. Page Arthur B raised its stake in shares of UnitedHealth Group by 40.5% in the fourth quarter. Page Arthur B now owns 5,421 shares of the healthcare conglomerate’s stock worth $1,350,000 after purchasing an additional 1,564 shares during the last quarter. Finally, Hemenway Trust Co LLC raised its stake in shares of UnitedHealth Group by 12.7% in the fourth quarter. Hemenway Trust Co LLC now owns 4,960 shares of the healthcare conglomerate’s stock worth $1,236,000 after purchasing an additional 560 shares during the last quarter. Institutional investors and hedge funds own 85.63% of the company’s stock.

Shares of NYSE UNH traded up $4.52 during mid-day trading on Friday, reaching $252.28. The company’s stock had a trading volume of 6,306,660 shares, compared to its average volume of 3,267,475. The firm has a market cap of $239.75 billion, a price-to-earnings ratio of 18.60, a price-to-earnings-growth ratio of 1.35 and a beta of 0.66. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping analysts’ consensus estimates of $3.60 by $0.13. The firm had revenue of $60.30 billion during the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.04 earnings per share. Research analysts expect that UnitedHealth Group Inc will post 14.71 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be given a $1.08 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.90. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date is Friday, June 14th. UnitedHealth Group’s payout ratio is currently 33.54%.

Several research firms have recently weighed in on UNH. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 11th. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Barclays decreased their price target on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. UBS Group began coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price target for the company. Finally, SunTrust Banks cut their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $290.84.

In related news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the sale, the director now directly owns 187,663 shares in the company, valued at $46,540,424. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $239.02, for a total value of $1,195,100.00. Following the completion of the sale, the director now owns 77,993 shares in the company, valued at $18,641,886.86. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $8,392,500 over the last quarter. 0.87% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Recession

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.